Literature DB >> 16482104

Identification by phage display of single-domain antibody fragments specific for the ODD domain in hypoxia-inducible factor 1alpha.

Arjan J Groot1, Peter Verheesen, Elike J Westerlaken, Eelke H Gort, Petra van der Groep, Niels Bovenschen, Elsken van der Wall, Paul J van Diest, Avi Shvarts.   

Abstract

Hypoxia triggers the transcription of genes responsible for cell survival via the key player transcription factor hypoxia-inducible factor 1alpha (HIF-1alpha). Overexpression of this protein has been implicated in cardiovascular disorders, carcinogenesis and cancer progression. For functional and diagnostic studies on the HIF-1alpha protein, we have identified single-domain antibody fragments directed against this protein by using a llama-derived nonimmune phage display library. This library displays the variable domains of the heavy-chain antibody subclass, found in these animals. Phage display selection with six recombinant HIF-1alpha proteins yielded five different antibody fragments. By epitope-mapping, we show that all five antibody fragments bind within the functionally important oxygen-dependent degradation domain of the HIF-1alpha protein. Two of these antibody fragments were engineered into bivalent antibodies that were able to detect human HIF-1alpha by immunohistochemistry, Western blotting and immunoprecipitation, and mouse HIF-1alpha by immunofluorescence and immunoprecipitation. These are the first single-domain antibody fragments that may be used in exploration of HIF-1alpha as a possible therapeutic target through molecular applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16482104     DOI: 10.1038/labinvest.3700395

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  10 in total

1.  COMMD1 disrupts HIF-1alpha/beta dimerization and inhibits human tumor cell invasion.

Authors:  Bart van de Sluis; Xicheng Mao; Yali Zhai; Arjan J Groot; Jeroen F Vermeulen; Elsken van der Wall; Paul J van Diest; Marten H Hofker; Cisca Wijmenga; Leo W Klomp; Kathleen R Cho; Eric R Fearon; Marc Vooijs; Ezra Burstein
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  A cell-penetrating peptide suppresses the hypoxia inducible factor-1 function by binding to the helix-loop-helix domain of the aryl hydrocarbon receptor nuclear translocator.

Authors:  Yu Wang; John D Thompson; William K Chan
Journal:  Chem Biol Interact       Date:  2013-02-27       Impact factor: 5.192

3.  Clostridial spores for cancer therapy: targeting solid tumour microenvironment.

Authors:  Brittany Umer; David Good; Jozef Anné; Wei Duan; Ming Q Wei
Journal:  J Toxicol       Date:  2012-06-07

4.  Development of VHH antibodies against dengue virus type 2 NS1 and comparison with monoclonal antibodies for use in immunological diagnosis.

Authors:  Aneela Fatima; Haiying Wang; Keren Kang; Liliang Xia; Ying Wang; Wei Ye; Jufang Wang; Xiaoning Wang
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

5.  Substrate thiophosphorylation by Arabidopsis mitogen-activated protein kinases.

Authors:  Franz Leissing; Mika Nomoto; Marco Bocola; Ulrich Schwaneberg; Yasuomi Tada; Uwe Conrath; Gerold J M Beckers
Journal:  BMC Plant Biol       Date:  2016-02-24       Impact factor: 4.215

Review 6.  Nanobody: A Small Antibody with Big Implications for Tumor Therapeutic Strategy.

Authors:  Shuyang Sun; Ziqiang Ding; Xiaomei Yang; Xinyue Zhao; Minlong Zhao; Li Gao; Qu Chen; Shenxia Xie; Aiqun Liu; Shihua Yin; Zhiping Xu; Xiaoling Lu
Journal:  Int J Nanomedicine       Date:  2021-03-22

Review 7.  Bacterial-Based Cancer Therapy (BBCT): Recent Advances, Current Challenges, and Future Prospects for Cancer Immunotherapy.

Authors:  Kajal H Gupta; Christina Nowicki; Eileena F Giurini; Amanda L Marzo; Andrew Zloza
Journal:  Vaccines (Basel)       Date:  2021-12-18

Review 8.  Single domain antibodies: promising experimental and therapeutic tools in infection and immunity.

Authors:  Janusz Wesolowski; Vanina Alzogaray; Jan Reyelt; Mandy Unger; Karla Juarez; Mariela Urrutia; Ana Cauerhff; Welbeck Danquah; Björn Rissiek; Felix Scheuplein; Nicole Schwarz; Sahil Adriouch; Olivier Boyer; Michel Seman; Alexei Licea; David V Serreze; Fernando A Goldbaum; Friedrich Haag; Friedrich Koch-Nolte
Journal:  Med Microbiol Immunol       Date:  2009-06-16       Impact factor: 3.402

9.  In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy.

Authors:  Ivan Matic; Martijn van Hagen; Joost Schimmel; Boris Macek; Stephen C Ogg; Michael H Tatham; Ronald T Hay; Angus I Lamond; Matthias Mann; Alfred C O Vertegaal
Journal:  Mol Cell Proteomics       Date:  2007-10-15       Impact factor: 5.911

Review 10.  Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy.

Authors:  Yaozhong Hu; Changxiao Liu; Serge Muyldermans
Journal:  Front Immunol       Date:  2017-11-02       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.